Genomic medicine, precision medicine, personalized medicine: what's in a name?
- PMID: 23872826
- PMCID: PMC3965175
- DOI: 10.1038/clpt.2013.101
Genomic medicine, precision medicine, personalized medicine: what's in a name?
Abstract
This issue of Clinical Pharmacology & Therapeutics is devoted to genomic medicine, and a reader may reasonably ask what we mean when we use those words. In the initial issue of the journal Genomics in 1987, McKusick and Ruddle pointed out that the descriptor "genome" had been coined in 1920 as a hybrid of "gene" and "chromosome," and that their new journal would focus on the "newly-developing discipline of mapping/sequencing (including analysis of the information)." A key milestone in the field was the generation of the first draft of a human genome in 2000, but this success really represents only one of many milestones in the journey from Mendel to MiSeq.
Conflict of interest statement
This work was supported in part by grants to D.M.R., who serves as site principal investigator for the Vanderbilt node of the PGRN (U19 HL065962) and of eMERGE (U01 HG006378), and to R.F.T. (U01 DA020830), who currently serves as PGRN Steering Committee chair. The authors declared no other conflicts of interest.
References
-
- Chisholm RL. The opportunities and challenges of implementing genomics-informed personalized medicine. Clin Pharmacol Ther. 2013;94:181–182. - PubMed
-
- Faruki H. Genomic testing: the clinical laboratory perspective. Clin Pharmacol Ther. 2013;94:190–192. - PubMed
-
- Passamani E. Educational challenges in implementing genomic medicine. Clin Pharmacol Ther. 2013;94:192–195. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
